Clinical Trial Update: Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks [NA]

View source ↗

Summary

An open-label study evaluating tolerance and efficacy of RV4421B in various populations with atopic dermatitis over 12 weeks; the trial status is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• RV4421B

Snippet

Sponsor: Pierre Fabre Dermo Cosmetique | Conditions: Atopic Dermatitis | NA | Status: NOT_YET_RECRUITING